Day 3: This session was devoted to the topic of non-neuronal (nerve) cells and their role in motor neurone disease.
Day 3: Recent research has proved that non-invasive ventilation (NIV) can improve the quality of life and the length of survival for many people with MND. But this therapy does not suit all patients.
Day 3: When did baseball legend Lou Gehrig first develop symptoms of MND - the condition that took his life, and to which he gave his name?
Day 3: Today's closing session highlighted these new findings as a stand-out from this year's meeting. (External link)
Listen to news and interviews from Day 2
Day 2: Interview with Debra Garside
Listen
Day 2: An integral part of the International Symposium on ALS/MND is the poster session, which usually takes place on the morning of day 2 of the meeting.
Day 2: Palliative care needs to move beyond simply providing end-of-life care for cancer patients, so that it can meet the needs of people with MND.
Day 2: “I thought that this afternoon’s session would be controversial and hotly debated, but we are all in agreement,” was the concluding comment at this afternoon’s session.
Day 2: Japan’s unique approach to caring for people with MND came under the spotlight today.
Listen to the news and interviews from Day 1
Day 1: Interview with Brian Dickie Listen
Day 1: What subtypes can tell us about MND Listen
Day 1: Two rare but possibly connected forms of MND that only affect people living on the Pacific Rim came under the spotlight at the opening session of the Symposium.
Day 1: A strong network of support is as important for the relatives who care for people with Motor Neurone Disease as it is for those who have the condition.
Day 1: Kennedy’s disease is a rare, slowly progressing form of MND that only affects men. In order to develop potential therapies for this condition, it is necessary to understand the underlying cause of the disease.
Day 1: Permanent respiratory support has changed the "end point" of MND by allowing people to live much longer with the condition.
Information for researchers